BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LearnPHP.co//NONSGML Rapid Fire Therapeutic Management in Anterior Segment Disease//EN
X-PUBLISHED-TTL:PT12H
X-ORIGINAL-URL:/events/
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:20190723T211620-8603787689-learnphp.co
DTSTAMP:20190723T211620
DTSTART:20190923T103001Z
DTEND:-00011130T222000Z
LOCATION:Ahmedabad
SUMMARY:FDA Grants Priority Review to Frontline Pembrolizumab for Urothelial Carcinoma
DESCRIPTION:FDA Grants Priority Review to Frontline Pembrolizumab for Urothelial Carcinoma
CLASS:PUBLIC
STATUS:CONFIRMED
PARTSTAT:ACCEPTED
END:VEVENT
END:VCALENDAR
